Does Lumentum (LITE) have what it takes to be a top stock pick for momentum investors? Let's find out.

Annaly (NLY) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Does Monarch Casino (MCRI) have what it takes to be a top stock pick for momentum investors? Let's find out.

Alnylam (ALNY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Does Mesoblast Limited (MESO) have what it takes to be a top stock pick for momentum investors? Let's find out.

Wayfair (W) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Genmab (GMAB) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

To gain an edge, this is what you need to know today.

Clinical efficacy and safety data will be presented from over 70 small-cell lung cancer (SCLC) patients in Hengrui's ongoing, multi-site, open label Phase 1 trial Data will include patients from the dose escalation and at multiple expansion doses U.S. Phase 1 trial of IDE849 in SCLC patients initiated in 3Q 2025 JIANGSU, China and SOUTH SAN FRANCISCO, Calif. , July 22, 2025 /PRNewswire/ -- IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a leading precision medicine oncology company, and Jiangsu Hengrui Pharmaceuticals Co., Ltd.

Medpace's Global CRO Reach Lends Credibility For Its 2025 Revenue Guidance Increase

Northrop Grumman Corporation (NYSE:NOC ) Q2 2025 Earnings Conference Call July 22, 2025 9:30 AM ET Company Participants Kathy J. Warden - Chair, CEO & President Kenneth B.

Investors are taking a "cautious" approach to General Motors (GM) after its earnings beat, according to Bob Lang. He says the company posted strong numbers in several metrics, including EV sales, which Bob says are second to Tesla (TSLA).

Top Performing Leveraged/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.

In this risk-on market, levered themes have gathered inflows along with some outsized YTD returns. Many of today's levered ETFs are single-stock ETFs focused on high-flying companies such as Palantir.

ATLANTA--(BUSINESS WIRE)--NCR Atleos Corporation (NYSE: NATL) (“Atleos”), a leader in expanding self-service financial access for financial institutions, retailers and consumers, today announced that Lloyds Banking Group has chosen Atleos' ATM as a Service (ATMaaS) proposition and latest technology, to introduce exciting branch modernization into its Manchester and Glasgow flagship locations. Lloyds Banking Group is the largest UK-based retail and commercial financial services provider. Aiming.

HUNTINGTON BEACH, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- BJ's Restaurants, Inc. (NASDAQ: BJRI) today announced that it will release its second quarter 2025 results after the market closes on Thursday, July 31, 2025. The Company will host an investor conference call at 1:30 p.m. (Pacific) that same day. The conference call will be broadcast live over the Internet. To listen to the conference call, please visit the “Investors” page of the Company's website located at http://www.bjsrestau r ants.com several minutes prior to the start of the call to register and download any necessary audio software. An archive of the …

We urge Apple (AAPL) investors, especially the bears, to switch their focus from hardware sales to subscription and service revenues. We expect these to continue roust growth in the incoming FQ3 earnings report and to further boost AAPL already-terrific margins for years to come. iPhone sales certainly face some headwinds and the current P/E valuation can feel off-putting.

Utz Brands, Inc. (NYSE:UTZ ) Q3 2024 Q&A Earnings Conference Call October 31, 2024 8:00 AM ET Company Participants Kevin Powers - SVP of IR Howard Friedman - CEO Ajay Kataria - CFO Conference Call Participants Andrew Lazar - Barclays Peter Galbo - Bank of America Michael Lavery - Piper Sandler Robert Dickerson - Jefferies Nik Modi - Nik Modi RBC Capital Markets Robert Moskow - TD Cowen Brian Holland - DA Davidson John Baumgartner - Mizuho Mitchell Pinheiro - Sturdivant Jim Salera - Stephens Operator Hello and welcome to the Utz Third Quarter 2024 Earnings Call. As a reminder, …

Johnson & Johnson eyes FDA nod to icotrokinra after phase III studies show strong skin clearance and safety in plaque psoriasis.

AGNC misses Q2 earnings estimates as lower net interest spread and book value weigh on its performance.